Abrdn Life Sciences Investors (NYSE:HQL) Short Interest Up 212.4% in December

Abrdn Life Sciences Investors (NYSE:HQL) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 77,800 shares, an increase of 212.4% from the December 15th total of 24,900 shares. Based on an average daily volume of 93,900 shares, the short-interest ratio is presently 0.8 days.

Abrdn Life Sciences Investors Trading Up 1.5 %

Shares of NYSE:HQL traded up $0.20 during trading on Wednesday, reaching $13.48. The stock had a trading volume of 143,765 shares, compared to its average volume of 127,424. The stock has a fifty day simple moving average of $13.94 and a two-hundred day simple moving average of $14.67. Abrdn Life Sciences Investors has a 52 week low of $12.76 and a 52 week high of $15.90.

Abrdn Life Sciences Investors Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 10th. Shareholders of record on Thursday, November 21st were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 14.84%. This is a boost from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.49. The ex-dividend date was Thursday, November 21st.

Institutional Investors Weigh In On Abrdn Life Sciences Investors

Several hedge funds and other institutional investors have recently made changes to their positions in HQL. Commonwealth Equity Services LLC grew its holdings in Abrdn Life Sciences Investors by 2.6% in the 2nd quarter. Commonwealth Equity Services LLC now owns 33,788 shares of the company’s stock valued at $479,000 after buying an additional 868 shares during the last quarter. Stephens Inc. AR grew its stake in shares of Abrdn Life Sciences Investors by 7.6% in the third quarter. Stephens Inc. AR now owns 12,707 shares of the company’s stock worth $192,000 after acquiring an additional 896 shares during the last quarter. Sanctuary Advisors LLC increased its position in Abrdn Life Sciences Investors by 11.4% during the third quarter. Sanctuary Advisors LLC now owns 13,256 shares of the company’s stock worth $183,000 after acquiring an additional 1,355 shares during the period. Future Financial Wealth Managment LLC acquired a new position in Abrdn Life Sciences Investors during the 3rd quarter valued at $30,000. Finally, Ashton Thomas Securities LLC bought a new stake in Abrdn Life Sciences Investors in the 3rd quarter valued at $148,000. 32.21% of the stock is owned by institutional investors and hedge funds.

About Abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.